402 related articles for article (PubMed ID: 30327280)
1. Accuracy and Variability of Prostate Multiparametric Magnetic Resonance Imaging Interpretation Using the Prostate Imaging Reporting and Data System: A Blinded Comparison of Radiologists.
Pickersgill NA; Vetter JM; Andriole GL; Shetty AS; Fowler KJ; Mintz AJ; Siegel CL; Kim EH
Eur Urol Focus; 2020 Mar; 6(2):267-272. PubMed ID: 30327280
[TBL] [Abstract][Full Text] [Related]
2. Prostate Magnetic Resonance Imaging Interpretation Varies Substantially Across Radiologists.
Sonn GA; Fan RE; Ghanouni P; Wang NN; Brooks JD; Loening AM; Daniel BL; To'o KJ; Thong AE; Leppert JT
Eur Urol Focus; 2019 Jul; 5(4):592-599. PubMed ID: 29226826
[TBL] [Abstract][Full Text] [Related]
3. Multiparametric Magnetic Resonance Imaging for the Detection of Clinically Significant Prostate Cancer: What Urologists Need to Know. Part 2: Interpretation.
Israël B; Leest MV; Sedelaar M; Padhani AR; Zámecnik P; Barentsz JO
Eur Urol; 2020 Apr; 77(4):469-480. PubMed ID: 31767492
[TBL] [Abstract][Full Text] [Related]
4. Interreader agreement of PI-RADS v. 2 in assessing prostate cancer with multiparametric MRI: A study using whole-mount histology as the standard of reference.
Girometti R; Giannarini G; Greco F; Isola M; Cereser L; Como G; Sioletic S; Pizzolitto S; Crestani A; Ficarra V; Zuiani C
J Magn Reson Imaging; 2019 Feb; 49(2):546-555. PubMed ID: 30187600
[TBL] [Abstract][Full Text] [Related]
5. Multiparametric Magnetic Resonance Imaging in Prostate Cancer Screening at the Age of 45 Years: Results from the First Screening Round of the PROBASE Trial.
Boschheidgen M; Albers P; Schlemmer HP; Hellms S; Bonekamp D; Sauter A; Hadaschik B; Krilaviciute A; Radtke JP; Seibold P; Lakes J; Arsov C; Gschwend JE; Herkommer K; Makowski M; Kuczyk MA; Wacker F; Harke N; Debus J; Körber SA; Benner A; Kristiansen G; Giesel FL; Antoch G; Kaaks R; Becker N; Schimmöller L
Eur Urol; 2024 Feb; 85(2):105-111. PubMed ID: 37863727
[TBL] [Abstract][Full Text] [Related]
6. Does the Prostate Imaging-Reporting and Data System (PI-RADS) version 2 improve accuracy in reporting anterior lesions on multiparametric magnetic resonance imaging (mpMRI)?
Hoffmann R; Logan C; O'Callaghan M; Gormly K; Chan K; Foreman D
Int Urol Nephrol; 2018 Jan; 50(1):13-19. PubMed ID: 29188489
[TBL] [Abstract][Full Text] [Related]
7. Multiparametric Magnetic Resonance Imaging Second Opinion May Reduce the Number of Unnecessary Prostate Biopsies: Time to Improve Radiologists' Training Program?
Luzzago S; Petralia G; Musi G; Catellani M; Alessi S; Di Trapani E; Mistretta FA; Serino A; Conti A; Pricolo P; Nazzani S; Mirone V; Matei DV; Montanari E; de Cobelli O
Clin Genitourin Cancer; 2019 Apr; 17(2):88-96. PubMed ID: 30527286
[TBL] [Abstract][Full Text] [Related]
8. Interreader variability in prostate MRI reporting using Prostate Imaging Reporting and Data System version 2.1.
Brembilla G; Dell'Oglio P; Stabile A; Damascelli A; Brunetti L; Ravelli S; Cristel G; Schiani E; Venturini E; Grippaldi D; Mendola V; Rancoita PMV; Esposito A; Briganti A; Montorsi F; Del Maschio A; De Cobelli F
Eur Radiol; 2020 Jun; 30(6):3383-3392. PubMed ID: 32052171
[TBL] [Abstract][Full Text] [Related]
9. Factors Influencing Variability in the Performance of Multiparametric Magnetic Resonance Imaging in Detecting Clinically Significant Prostate Cancer: A Systematic Literature Review.
Stabile A; Giganti F; Kasivisvanathan V; Giannarini G; Moore CM; Padhani AR; Panebianco V; Rosenkrantz AB; Salomon G; Turkbey B; Villeirs G; Barentsz JO
Eur Urol Oncol; 2020 Apr; 3(2):145-167. PubMed ID: 32192942
[TBL] [Abstract][Full Text] [Related]
10. The Accuracy of Prostate Magnetic Resonance Imaging Interpretation: Impact of the Individual Radiologist and Clinical Factors.
Pickersgill NA; Vetter JM; Raval NS; Andriole GL; Shetty AS; Ippolito JE; Kim EH
Urology; 2019 May; 127():68-73. PubMed ID: 30807773
[TBL] [Abstract][Full Text] [Related]
11. Association Between Prostate Imaging Reporting and Data System (PI-RADS) Score for the Index Lesion and Multifocal, Clinically Significant Prostate Cancer.
Stabile A; Dell'Oglio P; De Cobelli F; Esposito A; Gandaglia G; Fossati N; Brembilla G; Cristel G; Cardone G; Deho' F; Losa A; Suardi N; Gaboardi F; Del Maschio A; Montorsi F; Briganti A
Eur Urol Oncol; 2018 May; 1(1):29-36. PubMed ID: 31100225
[TBL] [Abstract][Full Text] [Related]
12. Application of Prostate Imaging Reporting and Data System Version 2 (PI-RADS v2): Interobserver Agreement and Positive Predictive Value for Localization of Intermediate- and High-Grade Prostate Cancers on Multiparametric Magnetic Resonance Imaging.
Chen F; Cen S; Palmer S
Acad Radiol; 2017 Sep; 24(9):1101-1106. PubMed ID: 28546032
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Biparametric and Multiparametric MRI for Clinically Significant Prostate Cancer Detection With PI-RADS Version 2.1.
Tamada T; Kido A; Yamamoto A; Takeuchi M; Miyaji Y; Moriya T; Sone T
J Magn Reson Imaging; 2021 Jan; 53(1):283-291. PubMed ID: 32614123
[TBL] [Abstract][Full Text] [Related]
14. Combined Clinical Parameters and Multiparametric Magnetic Resonance Imaging for Advanced Risk Modeling of Prostate Cancer-Patient-tailored Risk Stratification Can Reduce Unnecessary Biopsies.
Radtke JP; Wiesenfarth M; Kesch C; Freitag MT; Alt CD; Celik K; Distler F; Roth W; Wieczorek K; Stock C; Duensing S; Roethke MC; Teber D; Schlemmer HP; Hohenfellner M; Bonekamp D; Hadaschik BA
Eur Urol; 2017 Dec; 72(6):888-896. PubMed ID: 28400169
[TBL] [Abstract][Full Text] [Related]
15. Effect of observation size and apparent diffusion coefficient (ADC) value in PI-RADS v2.1 assessment category 4 and 5 observations compared to adverse pathological outcomes.
Abreu-Gomez J; Walker D; Alotaibi T; McInnes MDF; Flood TA; Schieda N
Eur Radiol; 2020 Aug; 30(8):4251-4261. PubMed ID: 32211965
[TBL] [Abstract][Full Text] [Related]
16. Prostate Imaging-Reporting and Data System Steering Committee: PI-RADS v2 Status Update and Future Directions.
Padhani AR; Weinreb J; Rosenkrantz AB; Villeirs G; Turkbey B; Barentsz J
Eur Urol; 2019 Mar; 75(3):385-396. PubMed ID: 29908876
[TBL] [Abstract][Full Text] [Related]
17. Prospective Evaluation of the Prostate Imaging Reporting and Data System Version 2 for Prostate Cancer Detection.
Mertan FV; Greer MD; Shih JH; George AK; Kongnyuy M; Muthigi A; Merino MJ; Wood BJ; Pinto PA; Choyke PL; Turkbey B
J Urol; 2016 Sep; 196(3):690-6. PubMed ID: 27101772
[TBL] [Abstract][Full Text] [Related]
18. Assessment of PI-RADS v2 categories ≥ 3 for diagnosis of clinically significant prostate cancer.
Patel NU; Lind KE; Garg K; Crawford D; Werahera PN; Pokharel SS
Abdom Radiol (NY); 2019 Feb; 44(2):705-712. PubMed ID: 30171296
[TBL] [Abstract][Full Text] [Related]
19. Deep-Learning-Based Artificial Intelligence for PI-RADS Classification to Assist Multiparametric Prostate MRI Interpretation: A Development Study.
Sanford T; Harmon SA; Turkbey EB; Kesani D; Tuncer S; Madariaga M; Yang C; Sackett J; Mehralivand S; Yan P; Xu S; Wood BJ; Merino MJ; Pinto PA; Choyke PL; Turkbey B
J Magn Reson Imaging; 2020 Nov; 52(5):1499-1507. PubMed ID: 32478955
[TBL] [Abstract][Full Text] [Related]
20. Interobserver Agreement and Accuracy in Interpreting mpMRI of the Prostate: a Systematic Review.
Annamalai A; Fustok JN; Beltran-Perez J; Rashad AT; Krane LS; Triche BL
Curr Urol Rep; 2022 Jan; 23(1):1-10. PubMed ID: 35226257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
